日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II trial of oral topotecan and intravenous carboplatin with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: A North Central Cancer Treatment Group Study

一项针对既往未接受治疗的广泛期小细胞肺癌患者的II期临床试验:口服拓扑替康联合静脉注射卡铂并辅以粒细胞集落刺激因子(G-CSF)支持治疗。一项北中部癌症治疗组研究

Bryce, Alan H; Mattar, Bassam; Hillman, Shauna L; Adjei, Alex A; Kugler, John W; Rowland, Kendrith Jr; Wender, Donald B; Soori, Gamini; Perez, Edith A; Jett, James R